HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ya-Zhen Qin Selected Research
Ya-Zhen Qin Research Topics
Disease
30
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2024 - 07/2006
18
Residual Neoplasm
10/2022 - 07/2008
16
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2021 - 03/2001
16
Leukemia
05/2021 - 06/2001
13
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
03/2024 - 04/2003
8
Neoplasms (Cancer)
12/2021 - 03/2001
7
Philadelphia Chromosome
10/2022 - 02/2014
6
Acute Promyelocytic Leukemia
11/2023 - 10/2003
5
Melanoma (Melanoma, Malignant)
01/2020 - 08/2016
3
Testicular Neoplasms (Testicular Cancer)
01/2020 - 02/2014
3
Wilms Tumor (Wilm's Tumor)
11/2019 - 05/2016
3
Infections
11/2018 - 12/2012
3
Hematologic Neoplasms (Hematological Malignancy)
04/2017 - 07/2008
2
Multiple Myeloma
12/2017 - 02/2014
2
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
04/2017 - 08/2016
2
Pathologic Complete Response
01/2017 - 06/2001
2
Disease Progression
02/2014 - 02/2012
1
Bronchiolitis Obliterans Syndrome
01/2022
1
Thrombocytopenia (Thrombopenia)
11/2019
1
Myeloid Leukemia (Leukemia, Myelocytic)
10/2019
1
Sarcoma (Soft Tissue Sarcoma)
10/2019
1
Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
07/2019
1
Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
11/2017
1
Autoimmune Diseases (Autoimmune Disease)
11/2017
1
Fever (Fevers)
11/2013
1
Myeloproliferative Disorders (Myeloproliferative Disorder)
03/2010
1
Essential Thrombocythemia
03/2010
1
Primary Myelofibrosis (Myelosclerosis)
03/2010
1
Hemorrhage
02/2007
1
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
07/2006
1
Refractory Anemia with Excess of Blasts (RAEM)
06/2001
Drug/Important Bio-Agent (IBA)
9
Imatinib Mesylate (Gleevec)
FDA Link
10/2019 - 01/2011
6
Antigens
IBA
01/2020 - 02/2014
6
Messenger RNA (mRNA)
IBA
09/2013 - 06/2001
5
Interferons
IBA
01/2022 - 11/2018
4
Biomarkers (Surrogate Marker)
IBA
03/2024 - 02/2014
4
Proteins (Proteins, Gene)
FDA Link
01/2024 - 07/2006
4
Tyrosine Kinase Inhibitors
IBA
10/2022 - 09/2013
3
Nucleophosmin
IBA
01/2020 - 02/2009
3
Arsenic
IBA
01/2018 - 08/2013
3
nilotinib
FDA Link
01/2017 - 02/2012
3
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
07/2004 - 03/2001
3
Monoclonal Antibodies
IBA
10/2003 - 02/2003
2
DNA (Deoxyribonucleic Acid)
IBA
03/2024 - 03/2010
2
Aldehyde Dehydrogenase
IBA
02/2021 - 09/2019
2
Nuclear Pore Complex Proteins (Nucleoporins)
IBA
12/2020 - 04/2016
2
Tretinoin (Retinoic Acid)
FDA Link
Generic
01/2018 - 08/2013
2
Cytarabine (Cytosar-U)
FDA Link
Generic
05/2016 - 11/2013
2
Aclarubicin
IBA
05/2016 - 11/2013
2
Phosphotransferases (Kinase)
IBA
07/2015 - 02/2012
2
promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein
IBA
02/2007 - 10/2003
1
Extracellular Matrix Proteins
IBA
03/2024
1
Retinoic Acid Receptors (Retinoic Acid Receptor)
IBA
11/2023
1
Cytokine Receptors (Cytokine Receptor)
IBA
01/2023
1
Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)
IBA
10/2022
1
Indicators and Reagents (Reagents)
IBA
01/2022
1
Dexamethasone (Maxidex)
FDA Link
Generic
12/2021
1
Metalloproteases (Metalloproteinases)
IBA
01/2020
1
Cancer Vaccines
IBA
01/2020
1
Zinc
IBA
01/2020
1
Calcium-Binding Proteins
IBA
01/2019
1
Interferon-alpha (Interferon Alfa)
IBA
11/2018
1
Bortezomib (Velcade)
FDA Link
12/2017
1
Jagged-1 Protein
IBA
11/2017
1
Inosine Triphosphate (ITP)
IBA
11/2017
1
Glycine (Aminoacetic Acid)
FDA Link
Generic
05/2017
1
Cysteine (L-Cysteine)
FDA Link
05/2017
1
ruxolitinib
IBA
01/2017
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
05/2016
1
Homoharringtonine
IBA
05/2016
1
Dasatinib (BMS 354825)
FDA Link
07/2015
1
Core Binding Factors (Core-Binding Factor)
IBA
12/2014
1
Transaminases (Aminotransferases)
IBA
11/2013
1
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
11/2013
1
RNA (Ribonucleic Acid)
IBA
04/2011
1
Thrombopoietin (c-mpl Ligand)
IBA
03/2010
1
Hemoglobins (Hemoglobin)
IBA
02/2007
1
Phosphotyrosine
IBA
07/2006
1
Complementary DNA (cDNA)
IBA
07/2004
1
tetraarsenic tetrasulfide
IBA
10/2003
1
Interleukin-1 Receptors (Interleukin 1 Receptor)
IBA
02/2003
1
Interleukin 1 Receptor Antagonist Protein (Anakinra)
FDA Link
02/2003
1
Cytokines
IBA
03/2001
Therapy/Procedure
27
Hematopoietic Stem Cell Transplantation
10/2022 - 08/2003
12
Drug Therapy (Chemotherapy)
01/2020 - 06/2001
11
Therapeutics
10/2022 - 05/2013
5
Immunotherapy
05/2021 - 08/2016
5
Transplantation
12/2020 - 04/2012
4
Aftercare (After-Treatment)
02/2021 - 02/2012
4
Stem Cell Transplantation
01/2020 - 08/2003
3
Induction Chemotherapy
10/2023 - 11/2013
2
Bone Marrow Transplantation (Transplantation, Bone Marrow)
04/2017 - 06/2001
1
Cell Transplantation
10/2022
1
Consolidation Chemotherapy
05/2016
1
CAG protocol
11/2013
1
Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
06/2001